20:50 , Oct 10, 2017 |  BC Innovations  |  Distillery Techniques

Biomarkers

TECHNOLOGY: SNPs A SNP on the GPX3-Tnip1 locus could help predict the risk of ALS. Genome-wide association studies in 13,811 ALS patients and 26,325 healthy volunteers identified an association between the disease and a SNP on...
07:00 , Sep 26, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Huntington's disease Glutathione peroxidase 1 (GPX1); glutathione peroxidase 3 plasma (GPX3) Yeast...
07:00 , Apr 26, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Prostate cancer Glutathione peroxidase 3 plasma (GPX3); tumor protein p53 inducible protein 3...
07:00 , Apr 9, 2009 |  BC Innovations  |  Cover Story

Opening up Rosetta

Merck & Co. Inc.'s soon-to-be shuttered Rosetta Inpharmatics Inc. unit is to be reborn as Sage, a not-for-profit institute that aims to provide precompetitive open access to the pharma's integrative genomics data set. This development...
07:00 , Apr 9, 2009 |  BC Innovations  |  Distillery Therapeutics

This week in therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Metabolic disease ...